Skip to main content

Table 1 Characteristics of COVID-19 Patients Based on Vitamin D Level

From: Lack of association between vitamin D insufficiency and clinical outcomes of patients with COVID-19 infection

 

Total

N (%)

25(OH) D level ≥ 30 ng/mL

N (%)

25(OH) D level ≤ 30 ng/mL

N (%)

P- value

Socio-demographic characteristics

Gender

 Female

66 (43.13)

23 (40.35)

43 (44.79)

0.601

 Male

87 (53.86)

34 (59.64)

53 (55.2)

Age group (years old)

 50>

55 (35.9)

13 (22.8)

42 (43.75)

0.020

 50–65

54 (35.3)

22 (38.59)

32 (33.33)

  > 65

44 (28.8)

22 (38.59)

22 (22.91)

Body mass index (BMI)

29.909 ± 5.81

29.15 ± 5.71

29.92 ± 5.92

0.321

Living area

 Rural

57 (37.25)

20 (35.08)

37 (38.54)

0.732

 Urban

96 (62.7)

37 (64.91)

59 (61.45)

Preexisting comorbidities

Diabetes

41 (26.79)

19 (38.59)

22 (22.91)

0.183

Hypertension

44 (28.75)

26 (45.61)

18 (18.75)

0.001

Cardiovascular disease

30 (19.6)

17 (29.82)

13 (13.54)

0.022

Dyslipidemia

10 (6.53)

1 (1.75)

9 (9.37)

0.091

Hypothyroidism

9 (5.88)

0

9 (9.37)

0.023

Asthma

6 (3.92)

0

6 (6.25)

0.081

Malignancy

3 (1.96)

2

1 (1.04)

0.550

Chronic liver disease

2 (1.3)

1 (1.75)

1 (1.04)

1

Chronic Kidney Disease

1 (0.65)

1 (1.75)

0

0.371

  1. P-values < 0.05 showed by boldface